Genome & Company (KOSDAQ: 314130)
South Korea
· Delayed Price · Currency is KRW
2,770.00
-125.00 (-4.32%)
Dec 19, 2024, 2:34 PM KST
Genome & Company Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 18, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 82,573 | 176,209 | 245,897 | 468,827 | 1,048,465 | 323,319 |
| Market Cap Growth | -44.46% | -28.34% | -47.55% | -55.28% | 224.28% | - |
| Enterprise Value | 86,437 | 151,242 | 185,907 | 383,841 | 1,026,945 | - |
| Last Close Price | 2665.00 | 6245.00 | 8725.00 | 17350.00 | 39750.00 | 19650.00 |
| PS Ratio | 2.30 | 12.33 | 17.46 | 1038.96 | 6962.78 | 7054.22 |
| PB Ratio | 1.63 | 1.55 | 1.63 | 4.13 | 9.11 | -8.51 |
| P/TBV Ratio | 4.01 | 4.83 | 3.73 | 8.10 | 9.84 | - |
| EV/Sales Ratio | 3.59 | 10.58 | 13.20 | 850.63 | 6819.87 | - |
| Debt / Equity Ratio | 0.30 | 0.23 | 0.04 | 0.06 | 0.02 | -0.19 |
| Asset Turnover | 0.14 | 0.09 | 0.09 | 0.00 | 0.00 | - |
| Inventory Turnover | 2.59 | 3.52 | 4.76 | - | - | - |
| Quick Ratio | 2.75 | 3.16 | 9.83 | 8.03 | 36.89 | 0.47 |
| Current Ratio | 3.02 | 3.44 | 10.49 | 8.32 | 37.00 | 0.48 |
| Return on Equity (ROE) | -32.72% | -38.36% | -43.15% | -31.52% | -80.89% | - |
| Return on Assets (ROA) | -14.71% | -20.55% | -23.17% | -17.48% | -21.33% | - |
| Return on Capital (ROIC) | -17.22% | -23.20% | -25.95% | -19.03% | -38.58% | - |
| Earnings Yield | -64.51% | -26.94% | -21.08% | -7.28% | -2.93% | -26.19% |
| FCF Yield | -31.38% | -28.99% | -20.50% | -6.19% | -1.88% | -3.32% |
| Buyback Yield / Dilution | 26.36% | -0.32% | -4.71% | -39.60% | -20.11% | - |
| Total Shareholder Return | 26.36% | -0.32% | -4.71% | -39.60% | -20.11% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.